Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

• Κύριοι συγγραφείς: Fangbo Zhang (Συγγραφέας), Feifei Guo (Συγγραφέας), Yang Liu (Συγγραφέας), Yi Zhang (Συγγραφέας), Defeng Li (Συγγραφέας), Hongjun Yang (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical applications have shown that Shema has ant...